At the completion of this educational session, learners will:
- Understand the history and principles that underlie durable antiviral suppression.
- Know with the range of alternative strategies currently under study to maintain suppression.
- Discuss how to best balance risks and benefits of alternative strategies in optimal patient care.
Cal Cohen is the Research Director of Community Research Initiative of New England, Clinical Research Director for Harvard Vanguard Medical Associates, and a Clinical Instructor at Harvard Medical School. Dr. Cohen earned his M.D. from the Albert Einstein College of Medicine, and his M.Sc. from the Harvard School of Public Health. Dr. Cohen's research has focussed on HIV antiviral trials since 1985, and he is currently a Vice-chair of the Scientific Steering Committee of the INSIGHT network, an NIH-supported International network of clinician-researchers. He received the Outstanding Physician Award by Harvard Vanguard Medical Associates, and the Ebert Teaching award by Harvard Pilgrim Health Care.
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.